Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 31INDUSTRY 27NIH 15NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 18Gynecologic 6Other neoplasm 4Sarcoma 2Lymphoid 2Thoracic 1Other hematologic neoplasm 1Head & Neck 1Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 134Urinary Bladder Neoplasms 47Kidney Neoplasms 38Carcinoma, Renal Cell 30Wilms Tumor 29Testicular Neoplasms 21Urethral Neoplasms 16Ovarian Neoplasms 15Neoplasm Metastasis 14Breast Neoplasms 14Neuroblastoma 12Sarcoma 11Teratoma 10Carcinoma, Non-Small-Cell Lung 9Testicular Germ Cell Tumor 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Ovarian Germ Cell Cancer 8Lung Neoplasms 8Endodermal Sinus Tumor 8Colorectal Neoplasms 7Burkitt Lymphoma 7Seminoma 6Osteosarcoma 6Neoplasms 6Colonic Neoplasms 6Carcinoma, Ovarian Epithelial 6Teratoma, Testicular 5Recurrence 5Pain 5Head and Neck Neoplasms 5

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Anus Neoplasms × Genitourinary × Clear all
NCT01209325 2020-08-11

Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males

AIDS Malignancy Consortium

Phase 2 Completed
149 enrolled 31 charts
GastrointestinalGenitourinaryOther neoplasm

Anus Neoplasms, Penile Neoplasms, Precancerous Conditions, HIV Infections, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡